$STJNY

Stella-Jones elected all directors with strong shareholder support; Q1 revenue rose 2.3% to $791M, but operating income fell 32.2% to $97M, raising profitability concerns.

Stella-Jones secures overwhelming shareholder approval with directors receiving 97.80-99.70% votes and executive pay endorsed at 91.52%.

Stella-Jones reported Q1 sales of $791M, up 2.3% YoY, but adjusted EBITDA margins contracted and EPS declined amid cost headwinds and currency challenges.

$SJ reports $3.5B revenue and 18.9% EBITDA margin in 2025. Q1 2026 earnings call scheduled May 6.

Stella-Jones posts $3.5B annual sales with $661M EBITDA. Company schedules Q1 2026 earnings call and hybrid shareholder meeting for May 6.

Stella-Jones leadership will present at Raymond James conference March 4, 2026, discussing business performance and strategy through fireside chat and investor meetings.

Stella-Jones will present at Raymond James 2026 Institutional Investor Conference on March 4 in Orlando, with CEO and CFO discussing business developments and strategy.